Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Kimberly-Clark
KMB
$36.4B
| $50.6M | 0.02% |
366,459
-483,271
| -57% | -$67.3M |
|
727
Noble Corp
NE
$7.39B
| $50.5M | 0.02% |
1,222,213
+217,615
| +22% | +$8.38M |
|
728
CALL
Albemarle
ALB
$16.9B
| $50.5M | 0.02% |
226,300
+221,100
| +4,252% | +$45.2M |
|
729
MYR Group
MYRG
$4.84B
| $50.5M | 0.02% |
364,722
-145,383
| -29% | -$19M |
|
730
3M
MMM
$92.3B
| $50.4M | 0.02% |
601,788
-380,829
| -39% | -$32.4M |
|
731
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.29B
| $50.3M | 0.02% |
+308,314
| New | +$46.3M |
|
732
Nu Holdings
NU
$70.4B
| $50M | 0.02% |
6,336,567
-1,036,136
| -14% | -$6.37M |
|
733
GFL Environmental
GFL
$14.8B
| $50M | 0.02% |
1,288,484
+1,273,060
| +8,254% | +$46.3M |
|
734
Columbia Banking Systems
COLB
$8.72B
| $50M | 0.02% |
2,464,371
+1,456,818
| +145% | +$30.8M |
|
735
Mastercard
MA
$509B
| $49.8M | 0.02% |
126,711
-353,885
| -74% | -$133M |
|
736
Dollar General
DG
$27.2B
| $49.8M | 0.02% |
293,031
-411,730
| -58% | -$81.4M |
|
737
Ericsson
ERIC
$33.5B
| $49.7M | 0.02% |
9,123,453
+9,109,518
| +65,371% | +$48.9M |
|
738
Cardinal Health
CAH
$53.4B
| $49.7M | 0.02% |
525,646
+182,205
| +53% | +$15.4M |
|
|
ESMT
739
DELISTED
EngageSmart, Inc.
ESMT
| $49.6M | 0.02% |
2,597,861
-554,281
| -18% | -$9.86M |
|
|
AL
740
DELISTED
Air Lease Corp
AL
| $49.6M | 0.02% |
1,184,946
+185,622
| +19% | +$7.35M |
|
|
PXD
741
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $49.6M | 0.02% |
239,300
-75,900
| -24% | -$16M |
|
|
RCM
742
DELISTED
R1 RCM Inc. Common Stock
RCM
| $49.5M | 0.02% |
2,684,049
+1,652,234
| +160% | +$26.8M |
|
743
CALL
Stryker
SYK
$126B
| $49.5M | 0.02% |
162,200
+54,800
| +51% | +$15.8M |
|
744
Zoetis
ZTS
$32.1B
| $49.3M | 0.02% |
286,386
-143,645
| -33% | -$24.8M |
|
745
PUT
Edwards Lifesciences
EW
$51.8B
| $49.3M | 0.02% |
522,500
+358,800
| +219% | +$31.2M |
|
746
Baxter International
BAX
$13.6B
| $49.3M | 0.02% |
1,081,221
-4,270,444
| -80% | -$186M |
|
747
iShares US Home Construction ETF
ITB
$2.27B
| $49.3M | 0.02% |
576,547
+449,983
| +356% | +$34.2M |
|
748
PUT
PepsiCo
PEP
$196B
| $49.1M | 0.02% |
265,300
-326,800
| -55% | -$61M |
|
749
Payoneer
PAYO
$2.41B
| $48.9M | 0.02% |
10,164,521
+2,803,588
| +38% | +$14M |
|
750
Corning
GLW
$129B
| $48.8M | 0.02% |
1,391,482
-938,242
| -40% | -$30.8M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.